INFLAMMATORY MYOFIBROBLASTIC TUMOR

Clinical trials for INFLAMMATORY MYOFIBROBLASTIC TUMOR explained in plain language.

Never miss a new study

Get alerted when new INFLAMMATORY MYOFIBROBLASTIC TUMOR trials appear

Sign up with your email to follow new studies for INFLAMMATORY MYOFIBROBLASTIC TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for kids with tough cancers: testing a targeted drug

Disease control Recruiting now

This study is testing a drug called brigatinib in children and young adults (ages 1 to under 26) with specific cancers that have a genetic change called ALK-positive. The cancers include anaplastic large cell lymphoma (ALCL), inflammatory myofibroblastic tumors (IMT), and other s…

Matched conditions: INFLAMMATORY MYOFIBROBLASTIC TUMOR

Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

INFLAMMATORY MYOFIBROBLASTIC TUMOR

Get alerted when new INFLAMMATORY MYOFIBROBLASTIC TUMOR trials appear

New hope for kids with tough cancers: testing a targeted drug